Biohealth Matrix
Natural health product licensed in Canada
- Licence holder
- Aperture Energetics Inc.
- NPN or DIN-HM
- 80043095
- Status
- Active licence
- Licence date
- 21 June 2013
- Revision date
- 12 July 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 20 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 60 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine C: up to 2,000 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Allium sativum Source : Bulbe | 35 mg | Not calculated |
| Potassium Source : Aspartate de potassium | 9.9 mg | 19,800 µg |
| Cuivre Source : Diglycinate cuivrique | 150 mcg | 300 µg |
| Eleutherococcus senticosus Source : Racine | 50 mg | Not calculated |
| L-phenylalanine Source : L-phénylalanine | 13 mg | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 400 UI | 10 mcg | 20 µg |
| Vitamine E Source : d-alpha-tocophérol Potency : 200 UI | 134 mg AT | Not calculated |
| Zinc Source : Aspartate de zinc | 1 mg | 2,000 µg |
| Borago officinalis Source : Graine(s) | 5 mg | Not calculated |
| Sélénium Source : Sélénométhionine | 30 mcg | 60 µg |
| Hydrastis canadensis Source : Racine et rhizome | 45 mg | Not calculated |
| L-isoleucine Source : L-isoleucine | 15 mg | Not calculated |
| L-Tyrosine Source : L-Tyrosine | 9 mg | Not calculated |
| Molybdène Source : Citrate de molybdène | 50 mcg | 100 µg |
| Riboflavine Source : Riboflavine | 10 mg | 20,000 µg |
| Vitamine C Source : Acide ascorbique | 1,000 mg | 2,000,000 µg |
| Calcium Source : Diglycinate de calcium | 50 mg | 100,000 µg |
| Bioflavonoïdes d'agrumes Source : Citrus aurantium | 100 mg | Not calculated |
| Bioflavonoïdes d'agrumes Source : Fruit | 100 mg | Not calculated |
| Acide aminoacétique Source : Glycine | 9.7 mg | Not calculated |
| Magnésium Source : Aspartate de magnésium | 18 mg | 36,000 µg |
| Thiamine Source : Chlorhydrate de thiamine | 13 mg | 26,000 µg |
| (2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one | 50 mg | Not calculated |
| Niacine Source : Acide nicotinique | 45 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Amidon du riz, chlorophylle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
An antioxidant. Helps to form red blood cells. Helps the body to metabolize carbohydrates, fats and proteins. Helps normal growth and development. Helps in tissue formation. Helps normal growth. Helps to maintain eyesight, skin, membranes and immune function. Helps in the development and maintenance of night vision. Helps in the development and maintenance of bones, cartilage, teeth and gums. An antioxidant for the maintenance of good health. Helps in connective tissue formation. Helps in wound healing. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Provides support for healthy glucose metabolism. Helps to produce and repair connective tissue. Helps to maintain proper muscle function. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80043095
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging